These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1534664)

  • 21. Fosinopril reduces left ventricular mass in untreated hypertensive patients: a controlled trial.
    Cheung BM; Lau CP
    Br J Clin Pharmacol; 1999 Feb; 47(2):179-87. PubMed ID: 10190653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of cilazapril therapy on diastolic filling and left ventricular hypertrophy in patients with arterial hypertension].
    De Simone R; Irace L; Perna B; Caruso C; Guida M; Iacono A
    Minerva Cardioangiol; 1993 May; 41(5):205-9. PubMed ID: 8355860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fosinopril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in essential hypertension.
    Murdoch D; McTavish D
    Drugs; 1992 Jan; 43(1):123-40. PubMed ID: 1372856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-exercise reduction in blood pressure in hypertensive subjects: effects of angiotensin converting enzyme inhibition.
    Beaulieu M; Nadeau A; Lacourcière Y; Cléroux J
    Br J Clin Pharmacol; 1993 Oct; 36(4):331-8. PubMed ID: 12959311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of amlodipine and fosinopril on heart rate variability and left ventricular mass in mild-to-moderate essential hypertension.
    Bilge AK; Atilgan D; Tükek T; Ozcan M; Ozben B; Koylan N; Meriç M
    Int J Clin Pract; 2005 Mar; 59(3):306-10. PubMed ID: 15857327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is the extrapolated adult dose of fosinopril safe and effective in treating hypertensive children?
    Li JS; Berezny K; Kilaru R; Hazan L; Portman R; Hogg R; Jenkins RD; Kanani P; Cottrill CM; Mattoo TK; Zharkova L; Kozlova L; Weisman I; Deitchman D; Califf RM
    Hypertension; 2004 Sep; 44(3):289-93. PubMed ID: 15262902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regression of left ventricular wall thickness during ACE-inhibitor treatment of essential hypertension is associated with an increase in insulin mediated skeletal muscle blood flow.
    Andersson PE; Lind L; Andrén B; Hänni A; Reneland R; Berne C; Lithell H
    Blood Press; 1998 May; 7(2):118-26. PubMed ID: 9657539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac performance during exercise in hypertensive patients without ventricular hypertrophy.
    Storto G; Nicolai E; Petretta M; Spinelli L; Acampa W; Evangelista L; Daniele S; Trimarco B; Cuocolo A
    Eur J Clin Invest; 2009 Aug; 39(8):664-70. PubMed ID: 19490065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antihypertensive effect of fosinopril, a new angiotensin converting enzyme inhibitor: findings of the Fosinopril Study Group II.
    Pool JL
    Clin Ther; 1990; 12(6):520-33. PubMed ID: 2149674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of fosinopril treatment on blood pressure during physical and mental stress test in essential hypertension.
    Yesilbursa D; Serdar A; Ilcol B; Türel B; Cordan J
    Blood Press; 1999; 8(5-6):269-72. PubMed ID: 10803486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fosinopril: a reappraisal of its pharmacology and therapeutic efficacy in essential hypertension.
    Wagstaff AJ; Davis R; McTavish D
    Drugs; 1996 May; 51(5):777-91. PubMed ID: 8861547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of renin-angiotensin system inhibition on left atrial function of hypertensive patients: an echocardiographic tissue deformation imaging study.
    Dimitroula H; Damvopoulou E; Giannakoulas G; Dalamanga E; Dimitroulas T; Sarafidis PA; Styliadis H; Hatzitolios A; Karvounis H; Parcharidis G
    Am J Hypertens; 2010 May; 23(5):556-61. PubMed ID: 20111009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Skeletal muscle angiotensin-converting enzyme and its relationship to blood pressure in primary hypertension and healthy elderly men.
    Reneland R; Haenni A; Andersson PE; Andrén B; Lithell H
    Blood Press; 1999; 8(1):16-22. PubMed ID: 10412878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.
    Pitt B; Reichek N; Willenbrock R; Zannad F; Phillips RA; Roniker B; Kleiman J; Krause S; Burns D; Williams GH
    Circulation; 2003 Oct; 108(15):1831-8. PubMed ID: 14517164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left ventricular filling after long-term angiotensin converting enzyme inhibition in congestive heart failure.
    Baur LH; Schipperheyn JJ; Cats VM; van der Wall EE; Baan J; van Dijk AD; Bruschke AV
    Eur Heart J; 1992 Nov; 13 Suppl E():52-6. PubMed ID: 1478210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapy of hypertension in the elderly: Fosinopril in Old Patients Study (FOPS)].
    Koch J; Greminger P; Simeon-Dubach D
    Praxis (Bern 1994); 1997 Nov; 86(45):1779-84. PubMed ID: 9446181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A single dose of cilazapril improves diastolic function in hypertensive patients.
    Marmor A; Green T; Krakuer J; Szucs T; Schneeweiss A
    Am J Med; 1989 Dec; 87(6B):61S-63S. PubMed ID: 2532463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fosinopril. Clinical pharmacokinetics and clinical potential.
    Shionoiri H; Naruse M; Minamisawa K; Ueda S; Himeno H; Hiroto S; Takasaki I
    Clin Pharmacokinet; 1997 Jun; 32(6):460-80. PubMed ID: 9195116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nifedipine improves left ventricular function in patients with hypertension.
    Zusman RM; Christensen DM; Higgins J; Boucher CA
    J Cardiovasc Pharmacol; 1991 Dec; 18(6):843-8. PubMed ID: 1725896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.